Humacyte, Inc. (HUMA) Tops Q2 EPS by 57c

Humacyte, Inc. (NASDAQ: HUMA) reported Q2 EPS of $0.35, $0.57 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $235.4 thousand.

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Barclays upgrades CubeSmart, cuts Public Storage on relative valuation
• Raymond James Previews Charles Schwab Corp. (SCHW) Earnings: 'Elevated Trading Volumes Drives Trading Revenue Upside'